Future directions in immune-checkpoint inhibitors in NSCLC

被引：0
|
作者：
Hayashi, Hidetoshi [1 ]
机构：
[1] Kindai Univ, Dept Med Oncol, Higashi Osaka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SST6-5
引用
收藏
页码：1225 / 1225
页数：1
相关论文
共 50 条
  • [1] Incorporating Immune-Checkpoint Inhibitors into Systemic Therapy of NSCLC
    Champiat, Stephane
    Ileana, Ecaterina
    Giaccone, Giuseppe
    Besse, Benjamin
    Mountzios, Giannis
    Eggermont, Alexander
    Soria, Jean-Charles
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) : 144 - 153
  • [2] Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI)
    Dorta Suarez, M.
    Jimenez Munarriz, B.
    Del Barrio, A.
    Garcia Ledo, G.
    Blanco Blanco, R.
    Conde Gallego, E.
    Hernandez Prieto, S.
    Lopez Rios, F.
    Cubillo Gracian, A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1349 - S1349
  • [3] Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC
    Signorelli, D.
    Fortunato, O.
    Pontis, F.
    Capizzuto, V.
    Ferri, R.
    Brambilla, M.
    Ferrara, R.
    Proto, C.
    Lo Russo, G.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Viscardi, G.
    Lobefaro, R.
    Nichetti, F.
    Ganzinelli, M.
    Zilembo, N.
    Colombo, M.
    Sozzi, G.
    Garassino, M. C.
    Jachetti, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S405 - S405
  • [4] Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
    Passiglia, Francesco
    Reale, Maria Lucia
    Cetoretta, Valeria
    Novello, Silvia
    [J]. IMMUNOTARGETS AND THERAPY, 2021, 10 : 9 - 26
  • [5] Beyond current immune-checkpoint inhibitors
    Torigoe, Toshihiko
    Chung, Junho
    [J]. CANCER SCIENCE, 2018, 109 : 622 - 622
  • [6] Immune-checkpoint inhibitors in pituitary malignancies
    Di Nunno, Vincenzo
    Franceschi, Enrico
    Tosoni, Alicia
    Gatto, Lidia
    Maggio, Ilaria
    Lodi, Raffaele
    Bartolini, Stefania
    Brandes, Alba A.
    [J]. ANTI-CANCER DRUGS, 2022, 33 (01) : E28 - E35
  • [7] Radiation in combination with immune-checkpoint inhibitors
    Mayor, Susan
    [J]. LANCET ONCOLOGY, 2015, 16 (04): : E162 - E162
  • [8] Hallmarks of Resistance to Immune-Checkpoint Inhibitors
    Karasarides, Maria
    Cogdill, Alexandria P.
    Robbins, Paul B.
    Bowden, Michaela
    Burton, Elizabeth M.
    Butterfield, Lisa H.
    Cesano, Alessandra
    Hammer, Christian
    Haymaker, Cara L.
    Horak, Christine E.
    McGee, Heather M.
    Monette, Anne
    Rudqvist, Nils-Petter
    Spencer, Christine N.
    Sweis, Randy F.
    Vincent, Benjamin G.
    Wennerberg, Erik
    Yuan, Jianda
    Zappasodi, Roberta
    Lucey, Vanessa M. Hubbard
    Wells, Daniel K.
    LaVallee, Theresa
    [J]. CANCER IMMUNOLOGY RESEARCH, 2022, 10 (04) : 372 - 383
  • [9] Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
    Zhang, Chenyue
    Zhang, Chenxing
    Wang, Haiyong
    [J]. CANCER LETTERS, 2023, 562
  • [10] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
12345